Global Next-Generation Gynecological Cancer Diagnostics Market Growth (Status and Outlook) 2022-2028

Code: RW00014732949
LP Information
Jul-2022
Life Sciences
111 Pages

As the global economy mends, the 2021 growth of Next-Generation Gynecological Cancer Diagnostics will have significant change from previous year. According to our (Publisher) latest study, the global Next-Generation Gynecological Cancer Diagnostics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Next-Generation Gynecological Cancer Diagnostics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Next-Generation Gynecological Cancer Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Next-Generation Gynecological Cancer Diagnostics market, reaching US$ million by the year 2028. As for the Europe Next-Generation Gynecological Cancer Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Next-Generation Gynecological Cancer Diagnostics players cover Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and Invitae Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Gynecological Cancer Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Ovarian Cancer Diagnosis
Cervical Cancer Diagnosis
Uterine Cancer Diagnosis

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Invitae Corporation
Konica Minolta, Inc.
BGI Genomics
CENTOGENE N.V.
Fulgent Genetics, Inc.
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
ARUP Laboratories
Myriad Genetics, Inc.
OPKO Health, Inc.
QIAGEN N.V.

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Next-Generation Gynecological Cancer Diagnostics Market Size 2017-2028
2.1.2 Next-Generation Gynecological Cancer Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Next-Generation Gynecological Cancer Diagnostics Segment by Type
2.2.1 Ovarian Cancer Diagnosis
2.2.2 Cervical Cancer Diagnosis
2.2.3 Uterine Cancer Diagnosis
2.3 Next-Generation Gynecological Cancer Diagnostics Market Size by Type
2.3.1 Next-Generation Gynecological Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Next-Generation Gynecological Cancer Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Next-Generation Gynecological Cancer Diagnostics Market Size by Application
2.5.1 Next-Generation Gynecological Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2022)
3 Next-Generation Gynecological Cancer Diagnostics Market Size by Player
3.1 Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Next-Generation Gynecological Cancer Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Next-Generation Gynecological Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Next-Generation Gynecological Cancer Diagnostics by Regions
4.1 Next-Generation Gynecological Cancer Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Next-Generation Gynecological Cancer Diagnostics Market Size Growth (2017-2022)
4.3 APAC Next-Generation Gynecological Cancer Diagnostics Market Size Growth (2017-2022)
4.4 Europe Next-Generation Gynecological Cancer Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Next-Generation Gynecological Cancer Diagnostics Market Size by Country (2017-2022)
5.2 Americas Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
5.3 Americas Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Gynecological Cancer Diagnostics Market Size by Region (2017-2022)
6.2 APAC Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
6.3 APAC Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Next-Generation Gynecological Cancer Diagnostics by Country (2017-2022)
7.2 Europe Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
7.3 Europe Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Next-Generation Gynecological Cancer Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.1 Global Next-Generation Gynecological Cancer Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Next-Generation Gynecological Cancer Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Next-Generation Gynecological Cancer Diagnostics Forecast
10.1.3 APAC Next-Generation Gynecological Cancer Diagnostics Forecast
10.1.4 Europe Next-Generation Gynecological Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Forecast
10.2 Americas Next-Generation Gynecological Cancer Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.2.2 Canada Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.2.3 Mexico Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.2.4 Brazil Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.3 APAC Next-Generation Gynecological Cancer Diagnostics Forecast by Region (2023-2028)
10.3.1 China Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.3.2 Japan Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.3.3 Korea Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.3.4 Southeast Asia Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.3.5 India Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.3.6 Australia Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.4 Europe Next-Generation Gynecological Cancer Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.4.2 France Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.4.3 UK Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.4.4 Italy Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.4.5 Russia Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.5 Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.5.2 South Africa Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.5.3 Israel Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.5.4 Turkey Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.5.5 GCC Countries Next-Generation Gynecological Cancer Diagnostics Market Forecast
10.6 Global Next-Generation Gynecological Cancer Diagnostics Forecast by Type (2023-2028)
10.7 Global Next-Generation Gynecological Cancer Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Quest Diagnostics Incorporated
11.1.1 Quest Diagnostics Incorporated Company Information
11.1.2 Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Product Offered
11.1.3 Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Quest Diagnostics Incorporated Main Business Overview
11.1.5 Quest Diagnostics Incorporated Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Information
11.3.2 Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.3.3 Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Agilent Technologies, Inc. Main Business Overview
11.3.5 Agilent Technologies, Inc. Latest Developments
11.4 Invitae Corporation
11.4.1 Invitae Corporation Company Information
11.4.2 Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Product Offered
11.4.3 Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Invitae Corporation Main Business Overview
11.4.5 Invitae Corporation Latest Developments
11.5 Konica Minolta, Inc.
11.5.1 Konica Minolta, Inc. Company Information
11.5.2 Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.5.3 Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Konica Minolta, Inc. Main Business Overview
11.5.5 Konica Minolta, Inc. Latest Developments
11.6 BGI Genomics
11.6.1 BGI Genomics Company Information
11.6.2 BGI Genomics Next-Generation Gynecological Cancer Diagnostics Product Offered
11.6.3 BGI Genomics Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 BGI Genomics Main Business Overview
11.6.5 BGI Genomics Latest Developments
11.7 CENTOGENE N.V.
11.7.1 CENTOGENE N.V. Company Information
11.7.2 CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.7.3 CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 CENTOGENE N.V. Main Business Overview
11.7.5 CENTOGENE N.V. Latest Developments
11.8 Fulgent Genetics, Inc.
11.8.1 Fulgent Genetics, Inc. Company Information
11.8.2 Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.8.3 Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Fulgent Genetics, Inc. Main Business Overview
11.8.5 Fulgent Genetics, Inc. Latest Developments
11.9 Illumina, Inc.
11.9.1 Illumina, Inc. Company Information
11.9.2 Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.9.3 Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Illumina, Inc. Main Business Overview
11.9.5 Illumina, Inc. Latest Developments
11.10 F. Hoffmann-La Roche Ltd
11.10.1 F. Hoffmann-La Roche Ltd Company Information
11.10.2 F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Product Offered
11.10.3 F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.10.5 F. Hoffmann-La Roche Ltd Latest Developments
11.11 Laboratory Corporation of America Holdings
11.11.1 Laboratory Corporation of America Holdings Company Information
11.11.2 Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Product Offered
11.11.3 Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Laboratory Corporation of America Holdings Main Business Overview
11.11.5 Laboratory Corporation of America Holdings Latest Developments
11.12 ARUP Laboratories
11.12.1 ARUP Laboratories Company Information
11.12.2 ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Product Offered
11.12.3 ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 ARUP Laboratories Main Business Overview
11.12.5 ARUP Laboratories Latest Developments
11.13 Myriad Genetics, Inc.
11.13.1 Myriad Genetics, Inc. Company Information
11.13.2 Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.13.3 Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Myriad Genetics, Inc. Main Business Overview
11.13.5 Myriad Genetics, Inc. Latest Developments
11.14 OPKO Health, Inc.
11.14.1 OPKO Health, Inc. Company Information
11.14.2 OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.14.3 OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 OPKO Health, Inc. Main Business Overview
11.14.5 OPKO Health, Inc. Latest Developments
11.15 QIAGEN N.V.
11.15.1 QIAGEN N.V. Company Information
11.15.2 QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Product Offered
11.15.3 QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 QIAGEN N.V. Main Business Overview
11.15.5 QIAGEN N.V. Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Next-Generation Gynecological Cancer Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Ovarian Cancer Diagnosis
Table 3. Major Players of Cervical Cancer Diagnosis
Table 4. Major Players of Uterine Cancer Diagnosis
Table 5. Next-Generation Gynecological Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 8. Next-Generation Gynecological Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 11. Global Next-Generation Gynecological Cancer Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Player (2020-2022)
Table 13. Next-Generation Gynecological Cancer Diagnostics Key Players Head office and Products Offered
Table 14. Next-Generation Gynecological Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Next-Generation Gynecological Cancer Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Next-Generation Gynecological Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Country (2017-2022)
Table 21. Americas Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 23. Americas Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 25. APAC Next-Generation Gynecological Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Region (2017-2022)
Table 27. APAC Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 29. APAC Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 31. Europe Next-Generation Gynecological Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Country (2017-2022)
Table 33. Europe Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 35. Europe Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Next-Generation Gynecological Cancer Diagnostics
Table 44. Key Market Challenges & Risks of Next-Generation Gynecological Cancer Diagnostics
Table 45. Key Industry Trends of Next-Generation Gynecological Cancer Diagnostics
Table 46. Global Next-Generation Gynecological Cancer Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Next-Generation Gynecological Cancer Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Next-Generation Gynecological Cancer Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Quest Diagnostics Incorporated Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 53. Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 54. Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Quest Diagnostics Incorporated Main Business
Table 56. Quest Diagnostics Incorporated Latest Developments
Table 57. Thermo Fisher Scientific Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 59. Thermo Fisher Scientific Inc. Main Business
Table 60. Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Thermo Fisher Scientific Inc. Latest Developments
Table 62. Agilent Technologies, Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 63. Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 64. Agilent Technologies, Inc. Main Business
Table 65. Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Agilent Technologies, Inc. Latest Developments
Table 67. Invitae Corporation Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 68. Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 69. Invitae Corporation Main Business
Table 70. Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Invitae Corporation Latest Developments
Table 72. Konica Minolta, Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 73. Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 74. Konica Minolta, Inc. Main Business
Table 75. Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Konica Minolta, Inc. Latest Developments
Table 77. BGI Genomics Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 78. BGI Genomics Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 79. BGI Genomics Main Business
Table 80. BGI Genomics Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. BGI Genomics Latest Developments
Table 82. CENTOGENE N.V. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 83. CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 84. CENTOGENE N.V. Main Business
Table 85. CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. CENTOGENE N.V. Latest Developments
Table 87. Fulgent Genetics, Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 88. Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 89. Fulgent Genetics, Inc. Main Business
Table 90. Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Fulgent Genetics, Inc. Latest Developments
Table 92. Illumina, Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 93. Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 94. Illumina, Inc. Main Business
Table 95. Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Illumina, Inc. Latest Developments
Table 97. F. Hoffmann-La Roche Ltd Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 98. F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 99. F. Hoffmann-La Roche Ltd Main Business
Table 100. F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. F. Hoffmann-La Roche Ltd Latest Developments
Table 102. Laboratory Corporation of America Holdings Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 103. Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 104. Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Laboratory Corporation of America Holdings Main Business
Table 106. Laboratory Corporation of America Holdings Latest Developments
Table 107. ARUP Laboratories Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 108. ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 109. ARUP Laboratories Main Business
Table 110. ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. ARUP Laboratories Latest Developments
Table 112. Myriad Genetics, Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 113. Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 114. Myriad Genetics, Inc. Main Business
Table 115. Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Myriad Genetics, Inc. Latest Developments
Table 117. OPKO Health, Inc. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 118. OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 119. OPKO Health, Inc. Main Business
Table 120. OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. OPKO Health, Inc. Latest Developments
Table 122. QIAGEN N.V. Details, Company Type, Next-Generation Gynecological Cancer Diagnostics Area Served and Its Competitors
Table 123. QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Product Offered
Table 124. QIAGEN N.V. Main Business
Table 125. QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. QIAGEN N.V. Latest Developments
List of Figures
Figure 1. Next-Generation Gynecological Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next-Generation Gynecological Cancer Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type in 2021
Figure 7. Next-Generation Gynecological Cancer Diagnostics in Hospitals
Figure 8. Global Next-Generation Gynecological Cancer Diagnostics Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Next-Generation Gynecological Cancer Diagnostics in Clinics
Figure 10. Global Next-Generation Gynecological Cancer Diagnostics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Next-Generation Gynecological Cancer Diagnostics in Others
Figure 12. Global Next-Generation Gynecological Cancer Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 14. Global Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Player in 2021
Figure 15. Global Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Next-Generation Gynecological Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Next-Generation Gynecological Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Next-Generation Gynecological Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Next-Generation Gynecological Cancer Diagnostics Value Market Share by Country in 2021
Figure 21. Americas Next-Generation Gynecological Cancer Diagnostics Consumption Market Share by Type in 2021
Figure 22. Americas Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 23. United States Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Region in 2021
Figure 28. APAC Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 29. China Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Country in 2021
Figure 36. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type in 2021
Figure 37. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 38. Germany Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 46. Egypt Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Next-Generation Gynecological Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 55. United States Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. China Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Next-Generation Gynecological Cancer Diagnostics Market Size 2023-2028 ($ Milli

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE